Science China Life Sciences

, Volume 61, Issue 8, pp 982–987 | Cite as

Early candidate biomarkers found from urine of glioblastoma multiforme rat before changes in MRI

  • Yanying Ni
  • Fanshuang Zhang
  • Manxia An
  • Wei Yin
  • Youhe GaoEmail author
Letter to the Editor


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Supplementary material

11427_2017_9201_MOESM1_ESM.docx (30 kb)
Supplementary material, approximately 30.3 KB.


  1. Abdullah-Soheimi, S.S., Lim, B.K., Hashim, O.H., and Shuib, A.S. (2010). Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin. Proteome Sci 8, 58.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Chen, L., Li, X., Liu, L., Yu, B., Xue, Y., and Liu, Y. (2015). Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function. Oncol Rep 33, 1465–1474.CrossRefPubMedGoogle Scholar
  3. Gao, Y.H. (2013). Urine—an untapped goldmine for biomarker discovery? Sci China Life Sci 56, 1145–1146.CrossRefPubMedGoogle Scholar
  4. Gao, Y. (2014). Roadmap to the urine biomarker era. MOJ Proteomics Bioinformatics in press doi: 10.15406/mojpb.2014.01.00005.Google Scholar
  5. Giatromanolaki, A., Sivridis, E., Mitrakas, A., Kalamida, D., Zois, C.E., Haider, S., Piperidou, C., Pappa, A., Gatter, K.C., Harris, A.L., and Koukourakis, M.I. (2014). Autophagy and lysosomal related protein expression patterns in human glioblastoma. Cancer Biol Ther 15, 1468–1478.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Gollapalli, K., Ray, S., Srivastava, R., Renu, D., Singh, P., Dhali, S., Bajpai Dikshit, J., Srikanth, R., Moiyadi, A., and Srivastava, S. (2012). Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics 12, 2378–2390.CrossRefPubMedGoogle Scholar
  7. Iwadate, Y., Matsutani, T., Hirono, S., Shinozaki, N., and Saeki, N. (2016). Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma. J Neurooncol 129, 101–107.CrossRefPubMedGoogle Scholar
  8. Kinross, J.M., Drymousis, P., Jiménez, B., and Frilling, A. (2013). Metabonomic profiling: a novel approach in neuroendocrine neoplasias. Surgery 154, 1185–1193.CrossRefPubMedGoogle Scholar
  9. Lee, K.B., Murray, S.S., Duarte, M.E.L., Spitz, J.F., Johnson, J.S., Song, K. J., Brochmann, E.J., Taghavi, C.E., Keorochana, G., Liao, J.C., and Wang, J.C. (2011). Effects of the bone morphogenetic protein binding protein spp24 (secreted phosphoprotein 24 kD) on the growth of human lung cancer cells. J Orthop Res 29, 1712–1718.CrossRefPubMedGoogle Scholar
  10. Li, J., Song, D., Xu, Y., Huang, Z., and Yue, W. (2008). In vitro study of haematoporphyrin monomethyl ether-mediated sonodynamic effects on C6 glioma cells. Neurol Sci 29, 229–235.CrossRefPubMedGoogle Scholar
  11. Liu, M.F., Hu, Y.Y., Jin, T., Xu, K., Wang, S.H., Du, G.Z., Wu, B.L., Li, L. Y., Xu, L.Y., Li, E.M., and Xu, H.X. (2015). Matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex activity in human glioma samples predicts tumor presence and clinical prognosis. Dis Markers 2015, 1–7.Google Scholar
  12. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W., and Kleihues, P. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97–109.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Lu, J., Ksendzovsky, A., Yang, C., Mehta, G.U., Yong, R.L., Weil, R.J., Park, D.M., Mushlin, H.M., Fang, X., Balgley, B.M., Lee, D.H., Lee, C. S., Lonser, R.R., and Zhuang, Z. (2012). CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade. J Neurosurg 117, 1022–1031.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Matsuura, H., and Nakazawa, S. (1985). Prognostic significance of serum alpha 1-acid glycoprotein in patients with glioblastoma multiforme: a preliminary communication.. J Neurol Neurosurg Psychiat 48, 835–837.CrossRefPubMedGoogle Scholar
  15. Osman, I., Bajorin, D.F., Sun, T.T., Zhong, H., Douglas, D., Scattergood, J., Zheng, R., Han, M., Marshall, K.W., and Liew, C.C. (2006). Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res 12, 3374–3380.CrossRefPubMedGoogle Scholar
  16. Quick, Q., and Skalli, O. (2010). α-Actinin 1 and α-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells. Exp Cell Res 316, 1137–1147.CrossRefPubMedGoogle Scholar
  17. Ramírez-Expósito, M.J., Mayas-Torres, M.D., Carrera-González, M.P., Jiménez-Pulido, S.B., Illán-Cabeza, N.A., Sánchez-Sánchez, P., Hueso-Ureña, F., Martínez-Martos, J.M., and Moreno-Carretero, M.N. (2014). Silver(I)/6-hydroxyiminolumazine compounds differently modify renin–angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells. J Inorg Biochem 138, 56–63.CrossRefPubMedGoogle Scholar
  18. San-Galli, F., Vrignaud, P., Robert, J., Coindre, J.M., and Cohadon, F. (1989). Assessment of the experimental model of transplanted C6 glioblastoma in wistar rats. J Neuro Oncol 7, 299–304.CrossRefGoogle Scholar
  19. Setti, M., Osti, D., Richichi, C., Ortensi, B., Del Bene, M., Fornasari, L., Beznoussenko, G., Mironov, A., Rappa, G., Cuomo, A., Faretta, M., Bonaldi, T., Lorico, A., and Pelicci, G. (2015). Extracellular vesiclemediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth. Oncotarget 6, 31413–31427.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Shao, C., Li, M., Li, X., Wei, L., Zhu, L., Yang, F., Jia, L., Mu, Y., Wang, J., Guo, Z., Zhang, D., Yin, J., Wang, Z., Sun, W., Zhang, Z., and Gao, Y. (2011). A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics 10, M111.010975.Google Scholar
  21. Wang, J.Y., and Bettegowda, C. (2015). Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies. J Neurooncol 123, 373–383.CrossRefPubMedGoogle Scholar
  22. Zhao, M., Li, M., Li, X., Shao, C., Yin, J., and Gao, Y. (2014). Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model. Proteome Sci 12, 42.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Yanying Ni
    • 1
    • 2
  • Fanshuang Zhang
    • 1
  • Manxia An
    • 1
  • Wei Yin
    • 1
  • Youhe Gao
    • 1
    • 3
    Email author
  1. 1.Department of Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic MedicinePeking Union Medical CollegeBeijingChina
  2. 2.Department of PathologyAviation General Hospital of China Medical UniversityBeijingChina
  3. 3.Department of Biochemistry and Molecular BiologyBeijing Normal University, Gene Engineering Drug and Biotechnology Beijing Key LaboratoryBeijingChina

Personalised recommendations